Success Metrics

Clinical Success Rate
97.1%

Based on 165 completed trials

Completion Rate
97%(165/170)
Active Trials
9(4%)
Results Posted
25%(42 trials)
Terminated
5(2%)

Phase Distribution

Ph not_applicable
19
9%
Ph phase_2
15
7%
Ph phase_1
49
22%
Ph phase_3
47
21%
Ph phase_4
85
39%

Phase Distribution

49

Early Stage

15

Mid Stage

132

Late Stage

Phase Distribution215 total trials
Phase 1Safety & dosage
49(22.8%)
Phase 2Efficacy & side effects
15(7.0%)
Phase 3Large-scale testing
47(21.9%)
Phase 4Post-market surveillance
85(39.5%)
N/ANon-phased studies
19(8.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

93.2%

165 of 177 finished

Non-Completion Rate

6.8%

12 ended early

Currently Active

9

trials recruiting

Total Trials

219

all time

Status Distribution
Active(14)
Completed(165)
Terminated(12)
Other(28)

Detailed Status

Completed165
unknown28
Recruiting9
Withdrawn7
Terminated5
Not yet recruiting4

Development Timeline

Analytics

Development Status

Total Trials
219
Active
9
Success Rate
97.1%
Most Advanced
Phase 4

Trials by Phase

Phase 149 (22.8%)
Phase 215 (7.0%)
Phase 347 (21.9%)
Phase 485 (39.5%)
N/A19 (8.8%)

Trials by Status

completed16575%
terminated52%
not_yet_recruiting42%
unknown2813%
withdrawn73%
enrolling_by_invitation10%
recruiting94%

Recent Activity

Clinical Trials (219)

Showing 20 of 219 trialsScroll for more
NCT07563491Not Applicable

Comparison of Esomeprazole Versus Vonoprazan in Gastroesophageal Reflux Disease

Completed
NCT06851468Not Applicable

Keverprazan Combined With Amoxicillin for the Treatment of Helicobacter Pylori

Completed
NCT05582174Phase 4

PPI Infusion Versus Oral Acid Pump Inhibitors for Bleeding Peptic Ulcers

Recruiting
NCT07399054

Efficacy and Safety of Esomeprazole 40 mg IV in Post-Surgical Patients Admitted to the ICU

Not Yet Recruiting
NCT06717269Phase 1

Relative Bioavailability of NX-5948 Tablets vs Capsules and the Effect of Covariates on the PK of NX-5948 Tablets

Recruiting
NCT07326904Phase 3

Study Comparing Fexuprazan and Esomeprazole in Patients With Gastroesophageal Reflux Disease

Completed
NCT07268820Phase 4

Heartburn, Gastroesophageal Reflux Disease

Recruiting
NCT05845645Phase 1

A Study to Test Bioavailability of of 2 New Formulations of UCB0599 in Healthy Participants in Part A and to Test Safety, Tolerability, and Pharmacokinetic (PK) of UCB0599 in Healthy Japanese and Chinese Participants in Part B

Completed
NCT06733675Phase 1

Safety and PK of Ceftibuten-ledaborbactam Etzadroxil Fixed-dose Combination

Recruiting
NCT07139366Phase 4

Saccharomyces Boulardii Combined With Bismuth Quadruple Therapy for Helicobacter Pylori Rescue Treatment

Recruiting
NCT07018635Phase 1

A Study to Assess the Effect of Itraconazole, Rifampin, and Acid-Reducing Agents on INCB161734 Pharmacokinetics When Administered Orally in Healthy Participants

Completed
NCT03866668Phase 2

A Study of Esomeprazole in Children With Autism

Recruiting
NCT06213818Phase 1

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of INCB160058 When Administered Orally to Healthy Adult Participant

Completed
NCT05742568Phase 4

Effects of High-dose Dual Therapy and Bismuth Quadruple Therapy for Helicobacter Pylori Eradication on Intestinal Microecology

Completed
NCT06168084Phase 4

Helicobacter Rescue Therapy With Vonorazon and Amoxicillin Dual Therapy Versus Bismuth-containing Quadruple Therapy

Completed
NCT06514274Phase 4

Study on The Efficacy and Safety of Vonoprazan-containing Berberine Triple Therapy in Helicobacter Pylori First-Line Eradication

Completed
NCT06359015Phase 4

Metformin and Esomeprazole in Preterm Pre-eclampsia

Terminated
NCT04720781Not Applicable

The Need of Revisiting to an Outpatient Clinic After the Prescription of Vonoprazan or Esomeprazole

Completed
NCT00357682Phase 3

A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia

Completed
NCT06793943Phase 1

A Study of Interaction of Zasocitinib (TAK-279) With Other Medicines in Healthy Adults

Completed

Drug Details

Intervention Type
DRUG
Total Trials
219